1. Home
  2. Live Updates
  3. Janssen research

Live Breaking News & Updates on Janssen research

Stay informed with the latest breaking news from Janssen research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Janssen research and stay connected to the pulse of your community

Johnson & Johnson submits regulatory applications to

        Media contact:Sophie DaneauSdaneau@its.jnj.com+33 6 3178 8798Investor contact:Raychel Kruperinvestor-relations@its.jnj.com For European and UK...

Japan , United-kingdom , Canada , Belgium , Beerse , Region-flamande , Canadian , David-lee , Sophie-daneau , Drug-administration , Johnson , Japan-pharmaceuticals

Johnson & Johnson receives positive CHMP opinion for

This positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line treatment of...

Singapore , Belgium , Saclay , France-general- , France , Beerse , Region-flamande , United-states , American , Nicolas-girard , Henar-hevia , Institut-curie

Johnson & Johnson : CARVYKTI®▼ (ciltacabtagene autoleucel; cilta-cel) is the first BCMA-targeted treatment approved by the European Commission for patients with relapsed and refractory multiple myeloma who have received at least one prior line of therapy

Media contact:




Investor contact:




...

Spain , United-states , China , Belgium , Beerse , Region-flamande , Chinese , American , Edmond-chan , Jenni-mildon , Ciltacabtagene-autoleucel , European-commission-grants-conditional-approval

Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034

/PRNewswire/ -- DelveInsight's Dry Age-related Macular Degeneration Market Insights report includes a comprehensive understanding of current treatment...

Japan , United-states , France , Spain , Germany , Italy , United-kingdom , American , Belite-bio , Ascentage-pharma , Exegenesis-bio , Iveric-bio

DelveInsight Business Research, LLP: Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034

DelveInsight Business Research, LLP: Dry Age-related Macular Degeneration Seven Major Market to Exhibit Growth at a CAGR of 19.8% by 2034
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Japan , Germany , France , Spain , United-states , Italy , United-kingdom , American , Exegenesis-bio , Iveric-bio , Cellcure-neurosciences , Ascentage-pharma

FDA Approves Cilta-Cel for Treatment of Relapsed, Refractory Multiple Myeloma

The indication is for adult patients with multiple myeloma who are refractory to lenalidomide and have previously received at least 1 line of therapy.

Binod-dhakal , Janssen-research-development , Division-of-hematology , Janssen-biotech-inc , Oncologic-drugs-advisory-committee , Johnson , College-of-wisconsin , Janssen-biotech , Postmodern-studio , Drugs-advisory-committee , Study-comparing , Versus-pomalidomide

NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects

NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-jersey , United-states , University-of-houston , Texas , Santa-clara-university , California , Newark , Chris-roberts , Bristol-myers-squibb , John-balchunas , Daniel-maiese , Los-angeles

DelveInsight Business Research, LLP: Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight

DelveInsight Business Research, LLP: Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states , Eppendorf , Nordrhein-westfalen , Germany , Berlin , America , Abu-dhabi , Chong-kun-dang , Eli-lilly , Prnewswire-delveinsight , Salubris-biotherapeutics , Dennis-riedl

Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight

The tissue banking market is experiencing a surge in demand due to several factors: the growing prevalence and occurrence of chronic illnesses, the expanding...

Eppendorf , Nordrhein-westfalen , Germany , Berlin , United-states , America , Chong-kun-dang , Salubris-biotherapeutics , Bristol-myers-squibb , Eli-lilly , Shruti-thakur , Prnewswire-delveinsight

NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects

NIIMBL Announces $10M for 8 New Biopharmaceutical Manufacturing Projects
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Texas , University-of-houston , New-jersey , Newark , Santa-clara-university , Los-angeles , Sartorius-stedim , Chris-roberts , Bristol-myers-squibb , John-balchunas